OH, US · AI law tracker

SB 164 — OH, US

SB 164 is an AI governance legislation from OH, currently introduced. Ohio SB 164 proposes to regulate the use of artificial intelligence by health insurers [1]. AIGI tracks 4 primary-source updates on this bill; the most recent was published on 2025-06-03.

Status & timeline

Regulatory stage
introduced
Bill status
introduced
Authority / governing body
Ohio General Assembly
Chamber
senate
Document type
legislation

Next deadline: No fixed deadline; legislation is proposed for the 2025-2026 General Assembly.

Subscriber only

Enforcement risk score

0
/ 100

Hypothetical or aspirational; no enforcement signal yet.

Intelligence briefs (4)

legislation introduced 6/3/2025

Ohio Bill Proposes AI Regulation for Health Insurers

Ohio SB 164 proposes to regulate the use of artificial intelligence by health insurers [1].

This signals an emerging legislative intent to establish specific AI governance parameters for the health insurance industry within Ohio.

Deadline: No fixed deadline; legislation is proposed for the 2025-2026 General Assembly.

Primary source →
legislation 4/1/2025

Ohio SB 164 Introduced to Regulate Health Insurer AI Use

Ohio Senate Bill 164 proposes regulating health insurers' use of artificial intelligence within the state [1].

This signals increasing state-level regulatory scrutiny for AI deployments in the healthcare insurance sector, impacting deployer obligations and risk assessments.

Deadline: No fixed deadline — bill is currently under legislative consideration.

Primary source →
legislation 4/1/2025

Ohio SB 164: Regulating AI Use by Health Insurers

Ohio Senate Bill 164 was introduced to regulate artificial intelligence use by health insurers [2].

This development signals a legislative focus on AI governance within the health insurance sector, potentially affecting deployer obligations.

Deadline: No fixed deadline — this is a bill in the legislative process.

Primary source →
legislation introduced 4/1/2025

Ohio SB 164 Proposed to Regulate AI Use by Health Insurers

Ohio Senate Bill 164 was introduced to regulate the use of artificial intelligence by health insurers [1].

This signals potential state-level oversight of AI applications in a critical regulated industry.

Deadline: No fixed deadline — proposed legislation from the 134th General Assembly (2021-2022).

Primary source →

Frequently asked questions

What is SB 164?
Ohio Senate Bill 164 (SB 164) has been introduced in the 136th General Assembly, with the stated purpose to regulate the use of artificial intelligence by health insurers [1]. This proposed legislation highlights an increasing legislative interest in establishing specific oversight and governance for AI systems deployed within the healthcare insurance sector. Primary source →
Why does SB 164 matter?
This signals an emerging legislative intent to establish specific AI governance parameters for the health insurance industry within Ohio. Primary source →
Who does SB 164 affect?
Organizations operating as health insurers in Ohio are within the scope of this proposed legislation. This includes entities that develop, deploy, or utilize AI systems for various functions, such as claims processing, risk assessment, fraud detection, and customer service. Deployers in the healthcare AI sector may benefit from monitoring this bill's progression to understand potential future compliance obligations related to AI risk management and governance. Primary source →
What are the key dates for SB 164?
No fixed deadline; legislation is proposed for the 2025-2026 General Assembly. Primary source →
What is the current status of SB 164?
As of the last published update, SB 164 is at the "introduced" stage, with bill status "introduced". Primary source →
Where can I find the primary source for SB 164?
The primary source for the most recent update is at https://www.legislature.ohio.gov/legislation/136/sb164. AIGI publishes the full citation chain plus every approved brief on this bill. Primary source →

Stay informed

Get briefs on every AI law, every morning.

Start 14-day trial →